Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide and the risk of a major cardiovascular event is highest among those with established disease. Ongoing management of these patients relies on the accurate assessment of their response to any prescribed therapy...

Full description

Bibliographic Details
Main Authors: Justine Cole, Rafael Zubirán, Anna Wolska, Ishwarlal Jialal, Alan T. Remaley
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Clinical Medicine
Subjects:
cardiovascular disease
ASCVD
atherosclerosis
dyslipidemia
apolipoprotein B
LDL-C
Online Access:https://www.mdpi.com/2077-0383/12/17/5737

Similar Items

Similar Items